2013no.

12

Ring a Bell

ADL

RCT

Randomized Controlled Trial

1979 1983
1984
1985
1986
1991
1996

ADL

validation Therapy

ROReality Orientation

A
DL

2 0 0 9

28

13

42

1045

710

2007

60013

2009

620

2030

25

24

866-0895 720-10965-32-8171
9

12

100

4060

09
No,0

72

10

4060

Broca

Wernicke

SSRI

3
3

4060

2010, 2012
vol.7

11

50.3g/

O2

63.6g/59.0g/

104.38g/

4.1

University of OxfordSmithB
The Johns Hopkins UniversityZandi

654740

Smith AD et al.

70168

Zandi PP et al.

, 2004; 61:

0.8mg/B12 0.5mg/

82-88EC

B6 20mg/2

64

0.76
1.08

EC

D A n g e r s U n i v e r s i t y
HospitalAnnweiler
Annweiler C et al.
, 2012; 67: 1205-1211Annweiler

, 2010; 5: e12244

D75

498D

12

530-0005 2-2-2 12F

06-4706-3315 www.mcp.co.jp

20132
RVT-SP12